Kawasaki H, Murawaki Y, Kimura N, Hirayama C
Hepatogastroenterology. 1982 Dec;29(6):252-5.
Plasma unconjugated bilirubin kinetics, gamma-glutamyltranspeptidase (GGT) and urinary excretion of d-glucaric acid were determined in 7 patients with Gilbert's syndrome, before and after phenobarbital treatment. The clearance of unconjugated bilirubin from plasma was significantly improved after treatment (p less than 0.005). Kinetic analysis of plasma disappearance data was associated with an increase in uptake and conjugation, and a decrease in reflux. Phenobarbital treatment resulted in significant increases in serum GGT activity (p less than 0.05) and urinary d-glucaric acid excretion (p less than 0.005). These results suggest that measurement or urinary d-glucaric acid by short-term administration of phenobarbital may be a better clinical index for hepatic microsomal enzyme induction than serum GGT activity.
对7例吉尔伯特综合征患者在苯巴比妥治疗前后测定了血浆非结合胆红素动力学、γ-谷氨酰转肽酶(GGT)及d-葡萄糖醛酸的尿排泄情况。治疗后血浆中非结合胆红素的清除率显著提高(p<0.005)。血浆消失数据的动力学分析显示摄取和结合增加,反流减少。苯巴比妥治疗导致血清GGT活性显著升高(p<0.05)及尿d-葡萄糖醛酸排泄增加(p<0.005)。这些结果表明,短期给予苯巴比妥后测定尿d-葡萄糖醛酸可能是比血清GGT活性更好的肝微粒体酶诱导临床指标。